Abstract:The outbreak of monkeypox, coupled with the onslaught of the COVID-19 pandemic is a critical communicable disease. This study aimed to systematically identify and review research done on preclinical studies focusing on the potential monkeypox treatment and immunization. The presented juxtaposition of efficacy of potential treatments and vaccination that had been tested in preclinical trials could serve as a useful primer of monkeypox virus. The literature identified using key terms such as monkeypox virus or management or vaccine stringed using Boolean operators was systematically reviewed. Pubmed, SCOPUS, Cochrane, and preprint databases were used, and screening was performed in accordance with PRISMA guidelines. A total of 467 results from registered databases and 116 from grey literature databases were screened. Of these results, 72 studies from registered databases and three grey literature studies underwent full-text screening for eligibility. In this systematic review, a total of 27 articles were eligible according to the inclusion criteria and were used. Tecovirimat, known as TPOXX or ST-246, is an antiviral drug indicated for smallpox infection whereas brincidofovir inhibits the viral DNA polymerase after incorporation into viral DNA. The ability of tecovirimat in providing protection to poxvirus-challenged animals from death had been demonstrated in a number of animal studies. Non-inferior with regard to immunogenicity was reported for the live smallpox/monkeypox vaccine compared with a single dose of a licensed live smallpox vaccine. The trial involving the live vaccine showed a geometric mean titre of vaccinia-neutralizing antibodies post two weeks of the second dose of the live smallpox/monkeypox vaccine. Of note, up to the third generation of smallpox vaccines—particularly JYNNEOS and Lc16m8—have been developed as preventive measures for MPXV infection and these vaccines had been demonstrated to have improved safety compared to the earlier generations.

Variations in gestation length in a colony of pipistrelle bats (Pipistrellus pipistrellus) from year to year.

Advancements in monkeypox vaccines development: a critical review of emerging technologies

Variations among cultured cells in glutathione peroxidase activity in response to selenite supplementation.

An overview on mRNA-based vaccines to prevent monkeypox infection

The Current State and Progress of Mpox Vaccine Research

Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies

Insights into the Transmission, Host Range, Genomics, Vaccination, and Current Epidemiology of the Monkeypox Virus

Monkeypox outbreak in the post-eradication era of smallpox

Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes

Research progress of Monkeypox and its current prevention and treatment options

Evaluation of the Clinical Relevance of the iceA1 Gene in Patients with Helicobacter pylori Infection in Japan

Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity

Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus

Treatment and Vaccination for Smallpox and Monkeypox

Researcher's suit against NCI wins mixed judgment.

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-emerging Human Monkeypox Virus

Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries

Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments

Monkeypox (Mpox) vs. Innate immune responses: Insights into evasion mechanisms and potential therapeutic strategies

Mpox treatment evolution: past milestones, present advances, and future directions

Prevention and Treatment of Monkeypox